Shares of Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $22.63 and traded as high as $23.98. Privia Health Group shares last traded at $23.94, with a volume of 3,338,673 shares traded.
Privia Health Group News Roundup
Here are the key news stories impacting Privia Health Group this week:
- Positive Sentiment: Third-quarter revenue was about $657 million, up 13.2% year over year and ahead of the roughly $611 million analyst consensus. Earnings also topped estimates, although reports cite different per-share figures, likely reflecting different earnings measures. Article: Privia Health posts better-than-expected sales and guides for strong full-year sales
- Positive Sentiment: Privia raised its full-year 2026 guidance across all key financial metrics. Year-to-date adjusted EBITDA reached $114.7 million, up 21.9% from the year-ago period, supporting the outlook upgrade. Article: Privia Health reports strong third-quarter and year-to-date 2026 results
Analyst Ratings Changes
PRVA has been the topic of several analyst reports. Zacks Research raised Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Privia Health Group in a research report on Tuesday, September 29th. Citigroup reissued a “buy” rating on shares of Privia Health Group in a research note on Thursday, July 23rd. Finally, Canaccord Genuity Group set a $32.00 target price on Privia Health Group in a report on Friday, August 7th. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Privia Health Group currently has a consensus rating of “Moderate Buy” and an average target price of $31.00.
Get Our Latest Report on Privia Health Group
Privia Health Group Stock Performance
The company has a 50 day moving average of $20.97 and a 200 day moving average of $22.63. The stock has a market capitalization of $3.06 billion, a price-to-earnings ratio of 114.01 and a beta of 0.76.
Privia Health Group (NASDAQ:PRVA – Get Free Report) last released its earnings results on Thursday, November 5th. The company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.12. The firm had revenue of $656.96 million for the quarter, compared to analyst estimates of $610.72 million. Privia Health Group had a net margin of 1.19% and a return on equity of 3.52%. The business’s quarterly revenue was up 13.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.29 earnings per share. As a group, research analysts expect that Privia Health Group, Inc. will post 0.27 EPS for the current fiscal year.
Hedge Funds Weigh In On Privia Health Group
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Rubicon Founders LLC acquired a new stake in shares of Privia Health Group during the second quarter worth about $153,635,863. Hsbc Holdings PLC raised its position in Privia Health Group by 164.8% during the 2nd quarter. Hsbc Holdings PLC now owns 100,213 shares of the company’s stock worth $2,602,000 after buying an additional 62,362 shares during the last quarter. Oppenheimer Asset Management Inc. purchased a new position in Privia Health Group during the second quarter worth about $5,841,000. Van Berkom & Associates Inc. raised its stake in shares of Privia Health Group by 5.4% during the 1st quarter. Van Berkom & Associates Inc. now owns 4,053,043 shares of the company’s stock worth $83,371,000 after buying an additional 208,787 shares in the last quarter. Finally, OneDigital Investment Advisors LLC acquired a new stake in Privia Health Group in the second quarter valued at $6,653,000. 94.48% of the stock is owned by institutional investors and hedge funds.
About Privia Health Group
Privia Health Group, Inc is a physician-enablement company that partners with independent medical practices to support the delivery of coordinated, value-based care. The company provides an integrated platform designed to help physicians manage clinical, administrative and financial functions while maintaining ownership and control of their practices.
Its services include practice management, electronic health record and technology support, revenue-cycle management, payer contracting, population-health analytics, care-management programs and administrative assistance.
Read More
- Five stocks we like better than Privia Health Group
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
